SGRY

16.40

2.21% -0.37

Handel nachbörslich: 16.40

Surgery Partners Inc (SGRY)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Schlusskurs vom Vortag:

$16.77

Offen:

$16.99

24-Stunden-Volumen:

858.84K

Relative Volume:

0.63

Marktkapitalisierung:

$2.14B

Einnahmen:

$3.34B

Nettoeinkommen (Verlust:

$97.10M

KGV:

-27.56

EPS:

-0.595

Netto-Cashflow:

$208.00M

1W Leistung:

-4.82%

1M Leistung:

+15.49%

6M Leistung:

+1.74%

1J Leistung:

-26.37%

1-Tages-Spanne:

$16.15

$16.99

1-Wochen-Bereich:

$16.15

$17.44

52-Wochen-Spanne:

$11.41

$24.10

Surgery Partners Inc Stock (SGRY) Company Profile

Firmenname

Surgery Partners Inc

Sektor

Healthcare (1096)

Branche

Medical Care Facilities (50)

Telefon

615-234-5900

Adresse

340 SEVEN SPRINGS WAY, BRENTWOOD, TN

Mitarbeiter

16,000

Twitter

@surgerypartners

Nächster Verdiensttermin

2026-08-04

Neueste SEC-Einreichungen

SGRY's Discussions on Twitter

Compare SGRY vs HCA, THC, DVA, FMS, EHC

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
SGRY Surgery Partners Inc	16.40	2.14B	3.34B	97.10M	208.00M	-0.595
HCA Hca Healthcare Inc	406.59	90.20B	76.39B	7.81B	7.93B	29.08
THC Tenet Healthcare Corp	204.25	17.59B	21.46B	2.65B	3.35B	19.23
DVA Davita Inc	232.80	14.94B	13.84B	1.10B	1.49B	10.42
FMS Fresenius Medical Care Ag Adr	24.02	12.90B	22.44B	1.35B	2.03B	1.9002
EHC Encompass Health Corp	110.16	10.93B	6.07B	793.80M	464.40M	5.9914

Surgery Partners Inc Stock (SGRY) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-09-18	Fortgesetzt	JP Morgan	Neutral
2025-07-28	Fortgesetzt	BofA Securities	Buy
2024-12-16	Eingeleitet	BofA Securities	Buy
2024-10-14	Eingeleitet	UBS	Buy
2024-10-11	Eingeleitet	KeyBanc Capital Markets	Sector Weight
2024-06-28	Eingeleitet	Macquarie	Outperform
2024-03-06	Eingeleitet	Barclays	Equal Weight
2023-11-14	Hochstufung	TD Cowen	Market Perform → Outperform
2023-06-02	Hochstufung	BofA Securities	Neutral → Buy
2023-05-12	Eingeleitet	Mizuho	Buy
2023-04-21	Eingeleitet	Cantor Fitzgerald	Overweight
2022-11-23	Bestätigt	RBC Capital Mkts	Outperform
2022-06-15	Herabstufung	BofA Securities	Buy → Neutral
2022-01-10	Fortgesetzt	Citigroup	Buy
2021-11-30	Eingeleitet	Barclays	Overweight
2021-11-29	Hochstufung	Stifel	Hold → Buy
2021-11-01	Eingeleitet	JP Morgan	Neutral
2021-10-18	Eingeleitet	SVB Leerink	Outperform
2021-09-10	Eingeleitet	Cowen	Market Perform
2021-06-23	Fortgesetzt	Stifel	Hold
2020-09-17	Bestätigt	The Benchmark Company	Buy
2020-04-27	Hochstufung	The Benchmark Company	Hold → Buy
2020-03-03	Herabstufung	The Benchmark Company	Buy → Hold
2020-01-14	Bestätigt	The Benchmark Company	Buy
2018-11-16	Eingeleitet	UBS	Neutral
2018-09-18	Hochstufung	BofA/Merrill	Neutral → Buy
2018-06-28	Hochstufung	Stifel	Sell → Hold
2018-01-30	Bestätigt	The Benchmark Company	Buy
2017-11-01	Herabstufung	BofA/Merrill	Buy → Neutral
2017-08-09	Herabstufung	KeyBanc Capital Mkts	Overweight → Sector Weight
2017-08-09	Herabstufung	Raymond James	Strong Buy → Mkt Perform
2017-08-09	Herabstufung	Stifel	Hold → Sell
2017-04-24	Bestätigt	Stifel	Hold
2017-03-10	Herabstufung	Stifel	Buy → Hold
2017-01-31	Eingeleitet	The Benchmark Company	Buy
2016-06-10	Eingeleitet	KeyBanc Capital Mkts	Overweight
2016-03-14	Bestätigt	RBC Capital Mkts	Outperform
2015-10-27	Eingeleitet	Stifel	Buy
2015-10-26	Eingeleitet	RBC Capital Mkts	Outperform
2015-10-26	Eingeleitet	Raymond James	Strong Buy

Alle ansehen

Surgery Partners Inc Aktie (SGRY) Neueste Nachrichten

01:06 AM

Surgery Partners (SGRY) Could Be 9% Undervalued As Outpatient Surgery Growth Narrative Builds - Yahoo Finance

01:06 AM

Jul 09, 2026

Avoiding Lag: Real-Time Signals in (SGRY) Movement - Stock Traders Daily

Jul 09, 2026

Beyond the hospital walls: Why USPI is becoming Tenet's growth engine - MSN

Jul 09, 2026

Jul 08, 2026

Fast-paced Momentum Stock Surgery Partners (SGRY) Is Still Trading at a Bargain - Yahoo Finance

Jul 08, 2026

Jul 07, 2026

Surgery Partners focuses on specialty care as investors watch US healthcare trends - ad-hoc-news.de

Jul 07, 2026

Jul 06, 2026

Surgery Partners | 4: Statement of changes in beneficial ownership of securities-Officer Doherty David T - Moomoo

Jul 06, 2026

Surgery Partners (SGRY) Edges Lower Near Support as Consolidation ContinuesWide Range Bar - dars.gov.et

Jul 06, 2026

Jul 05, 2026

Enterprise value to EBITDA forward of Surgery Partners, Inc. – NASDAQ:SGRY - TradingView

Jul 05, 2026

Enterprise value to EBITDA forward of Surgery Partners, Inc. – DUS:1SP - TradingView

Jul 05, 2026

Jul 04, 2026

Surgery Partners stock rating maintained at Overweight by Cantor - Investing.com Nigeria

Jul 02, 2026

Jul 01, 2026

Cantor Fitzgerald reiterates Surgery Partners stock rating at Overweight By Investing.com - Investing.com Nigeria

Jul 01, 2026

Cantor Fitzgerald reiterates Surgery Partners stock rating at Overweight - Investing.com

Jul 01, 2026

Jun 30, 2026

Price to book forward of Surgery Partners, Inc. – NASDAQ:SGRY - TradingView

Jun 30, 2026

Enterprise value to revenue forward of Surgery Partners, Inc. – FWB:1SP - TradingView

Jun 30, 2026

Jun 29, 2026

Price to sales forward of Surgery Partners, Inc. – NASDAQ:SGRY - TradingView

Jun 29, 2026

Price to earnings forward of Surgery Partners, Inc. – FWB:1SP - TradingView

Jun 29, 2026

Jun 28, 2026

Discipline and Rules-Based Execution in SGRY Response - Stock Traders Daily

Jun 28, 2026

Jun 27, 2026

Surgery Partners, Inc. Actuals & Estimates (NASDAQ:SGRY) - TradingView

Jun 27, 2026

Jun 26, 2026